Jake Bieber

Jake Bieber, an analyst at ATP, assists the firm in conducting due diligence on promising therapeutic targets and investment opportunities. He was first introduced to biotechnology investing at RTW Investments, where he evaluated novel drug targets apt for therapeutic development.

Jake earned his PhD in bioengineering jointly from the University of California, Berkeley and the University of California, San Francisco, where he was also awarded the ARCS scholarship. For his PhD, Jake developed a high-throughput gut organoid system to screen drugs for gastrointestinal toxicity.